SkinBioTherapeutics PLC (SBTX)

London
13.25
0.00(0.00%)
  • Volume:
    153,191
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    13.25 - 13.25

SBTX Overview

Prev. Close
13.25
Day's Range
13.25-13.25
Revenue
128K
Open
13.25
52 wk Range
11.34-30.63
EPS
-0.019
Volume
153,191
Market Cap
22.94M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
406,232
P/E Ratio
-8.63
Beta
2.56
1-Year Change
-44.21%
Shares Outstanding
173,138,854
Next Earnings Date
-
What is your sentiment on SkinBioTherapeutics?
or
Market is currently closed. Voting is open during market hours.

SkinBioTherapeutics PLC Company Profile

SkinBioTherapeutics PLC Company Profile

SkinBioTherapeutics plc is a United Kingdom-based life sciences company, which is focused on skin health. The principal activity of the Company and its subsidiaries is the identification and development of technology that harnesses the human microbiome to improve health. The Company's platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company is targeting five specific skin healthcare sectors, such as cosmetics skincare, food supplements for the treatment of skin conditions, medical skin care, infection control in both the home and the hospital environment, and pharmaceuticals for the prescribed treatment of skin conditions. The Company's product, AxisBiotix-Ps, is a food supplement to address the symptoms of mild to moderate psoriasis. The Company is also focused on the application of the SkinBiotix technology in the treatment of various classes of skin wounds.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • 26/7p
    0
    • Creeping up again....
      0
      • Buying has increased. news? Opta?
        0
        • is it back on track now? begin climbing back to March highs
          0
          • oh dear. Sales ' materially' below
            0
            • up 19.02%.....admittedly only recovering the fall earlier this month. Nevertheless, worth following.
              0
              • rising well....can triple easily from here with new product sales
                0
                • 3 days to launch
                  0
                  • 5 days to go until the launch ( soft).
                    0
                    • A remarkable opportunity for growth from q4 onwards. Psoriasis suffering to reduce significantly.
                      0